eMolecules acquires Synple Chem AG

"We are thrilled to welcome the highly reputable and talented Synple team into eMolecules"

26-Sep-2024 - eMolecules, Inc. announced that it has acquired Synple Chem AG ("Synple"). Synple was founded in 2016 as a Spin-off from ETH Zürich. Synple specializes in automated chemical synthesis systems and solutions for small molecules drug discovery customers. WithSynple's virtual compound library, which ...

Researchers develop efficient process for chemical terpene synthesis

Potential applications in food, cosmetics and pharmaceutical industries

20-Feb-2023 - A team of scientists led by Professor Tanja Gulder at Leipzig University’s Institute of Organic Chemistry, together with colleagues from the University of Regensburg, has developed a simplified and efficient method for the artificial production of terpenes. Terpenes are a very extensive and ...

Artificial intelligence to reduce costs and improve efficiency in drug discovery

Chemical.AI and NovAliX reached a milestone in collaboration

24-Jan-2023 - Chemcial.AI announces the collaboration with NovAliX -a world-leading Drug Discovery CRO company- has reached a milestone. On January 25, 2021, Chemical.AI announced a strategic cooperation with NovAliX in the field of AI-assisted drug discovery. Over the past two years, ChemAIRS, developed by ...

Bacterial toxin renders algae motionless

Team of biologists and chemists discover the mode of action of a bacterial toxin

05-Jan-2023 - Biologists and chemists at the University of Jena decipher properties of a bacterial toxin that renders the unicellular green algae Chlamydomonas reinhardtii motionless. The toxin appears to hijak the calcium channels of the target algae, causing a rapid influx of calcium ions that within one ...

Modified enzyme brings value to lignin monomers

Conversion of lignin into valuable chemicals

01-Dec-2022 - The chemical industry faces the challenge of replacing fossil-based building blocks with green alternatives. Biomass is an interesting source of carbon-based molecules. It is also underused because some 25 percent of all plant biomass is in the form of lignin, a biopolymer that, so far, can only ...

XuanZhu BioPharm and Chemical.AI announce collaboration in drug discovery

22-Sep-2022 - XuanZhu BioPharm and Chemical.AI announce collaboration focusing on cancer, metabolism, digestion and other fields, jointly to develop new drugs with proprietary intellectual property rights. Back in 2019, Chemical.AI has closed Angel Round with FreeS Fund, and in early 2021, Series A Round led ...

Light-powered microbes are super-producing chemical factories

New method allows bacteria to use light for external energy to accelerate biomanufacturing of target compounds without disrupting the host microorganism's natural metabolism

14-Apr-2022 - Sharing is key to living in society, whether it’s toddlers sharing toys or nations sharing natural resources; but there’s no avoiding the fact that one side getting more means that the other side gets less. Now, researchers from Osaka University, in collaboration with the University of Shizuoka ...

Sustainable High Efficiency Hydrogenation Biocatalysis

Cleaner, safer and more efficient chemical manufacture

27-Oct-2021 - UK-based HydRegen are using a DrySyn OCTO reaction station from Asynt to help develop a next generation biocatalyst system that enables cleaner, safer, and more efficient chemical manufacture. HydRegen spun-out from the Vincent Group in the Dept. of Chemistry at the University of Oxford in March ...

Hope in the fight against cancer: They build proteins that are not known to nature

Basel-​based biotech startup has big ideas for the future: it aims to take protein engineering into a new era

15-Jun-2021 - Using chemical synthesis, Bright Peak Therapeutics can produce proteins that have never before existed. This holds great potential for cancer immunotherapy. The Basel-​based spin-​off has its beginnings at ETH Zurich. Jeffrey Bode’s long, bold journey began over an after-​work beer in Tokyo. A ...

Inhoffen Medal 2019 awarded to specialist for synthetic organic chemistry

08-Apr-2019 - Medically relevant compounds can often be found in nature. To make them suitable for drugs, they need to be isolated from their natural sources. If sufficient quantities of the agent cannot be isolated in that manner, chemical synthesis comes into play. Without chemical synthesis, many agents ...